April 1, 2018 – The rise in skin cancer deaths over the last 10 years has not changed the attitude of a quarter of Brits when it comes to achieving a summer glow – despite 2,500 deaths annually from the disease.
Biotechnology company Novan Therapeutics has announced that it has received encouraging results from a phase 2b study analysing a nitric-oxide topical gel candidate drug. SB204, which is the company’s leading drug candidate for the treatment of acne vulgaris, was used in the trial and produced significant results on inflammatory and non-inflammatory lesions at week 12 […]
A study published in BioMed Central (BMC) Dermatology has suggested that the outcome from clinical treatment with adjuvant therapies, such as facial cleansing, topical treatments and moisturising, can greatly affect the improvement of mild-to-moderate acne vulgaris. The study, which evaluated 643 participants in an observational, non-interventional prospective study, assessed the effects of both clinical and […]